Citations

Showing 10 of 108152 citations.

Use of a Wearable EEG Headband as a Meditation Device for Women With Newly Diagnosed Breast Cancer: A Randomized Controlled Trial
Millstine, Denise , Bhagra, Anjali , Jenkins, Sarah M. , Croghan, Ivana T. , Nguyen, Minh-Doan T., Pruthi, Sandhya , Millstine, Denise M, Stan, Daniela L., Pruthi, Sandhya , Stan, Daniela , Boughey, Judy C. , Nguyen, Minh-Doan T.

Mayo Clinic

Integrative Cancer Therapies | September 30, 2019 | Volume: 18 | Issue: No issue available | Pages: No page available

10.1177/1534735419878770 | PMID 31566031 Get It

Background: Breast cancer diagnosis and treatment affect quality of life and stress and are associated with fatigue. Meditation interventions are effective strategies for patients with breast cancer but are often limited by poor access, high cost, substantial time commitment, and poor adherence. In this feasibility study, we investigated the use of a portable, wearable, electroencephalographic device for guided meditation practices by breast cancer patients during the period from breast cancer diagnosis until 3 months after surgical treatment. Methods: We enrolled women (age = 20-75 years) who had received a recent diagnosis of breast cancer and planned to undergo surgical treatment. Participants were randomly assigned to perform guided meditation with the device (intervention group) or receive CD-based stress-reduction education (control group). Surveys were used to measure stress, quality of life, and fatigue at baseline, within 4 days before surgery, up to 14 days after surgery, and at 3 months after surgery. Results: In the intervention group, 15 of 17 participants (88.2%) completed the study; in the control group, 13 of 13 participants completed the study (100%). Participants in both groups had less fatigue and stress and improved quality of life at 2 weeks and 3 months after surgery compared with baseline, but there were no significant intergroup differences at any time point. Conclusion: The use of this wearable electroencephalographic device for meditation is a feasible strategy for patients with breast cancer.
Commentary
Donato, Leslie J.

Mayo Clinic

Clinical Chemistry | September 30, 2019 | Volume: 65 | Issue: 10 | Pages: 1219-1219

10.1373/clinchem.2019.304543 | PMID 31570414 Get It

Eyebrow Height Changes with Aging: A Systematic Review and Meta-analysis
Kelarji, Ahmad Beshr , Jawhar, Cham Shaban, Banuelos, Joseph, Taslakian, Editt N. , Wahood, Waseem , Vyas, Krishna S. , Taslakian, Editt, Asaad, Malke , Sharaf, Basel

Mayo Clinic

Plastic and Reconstructive Surgery - Global Open | September 30, 2019 | Volume: 7 | Issue: 9 | Pages: e2433

10.1097/gox.0000000000002433 | PMID 31942395 Get It

Background: The eyebrows play an important role in emotional facial expressions, nonverbal communication, and facial esthetics. A comprehensive understanding of the mechanisms underlying eyebrow aging is vital in allowing plastic surgeons to appropriately address these age-related changes and to recreate an aesthetically desirable outcome for patients seeking brow rejuvenation. The aim of this study is to summarize the current literature on eyebrow height changes with aging. Methods: A comprehensive search was conducted across several databases to identify all published studies that reported changes of eyebrow position or height with aging, from 1946 to January 2019. Studies that reported eyebrow position at the level of medial canthus, mid-pupil, and lateral canthus were included in a meta-analysis. Results: A total of 346 articles were initially identified, of which 19 met our inclusion criteria. Of 3,634 patients who were identified, 2,237 (64%) were females and 1,274 (36%) were males. Eyebrow height showed significant increase with aging at the level of medial canthus (mean difference 1.4 mm; 95% CI: 0.22–2.59; P = 0.02), and the level of mid-pupil (mean difference 1.17 mm; 95% CI: 0.54–1.8; P = 0.0002). However, no significant difference was found at the level of lateral canthus (mean difference 0.19 mm; 95% CI: −0.87 to 1.25; P = 0.72). Conclusions: Based on the reviewed literature to date, the medial eyebrow height increases with age, whereas it remains stable at the level of the lateral canthus. These results should be considered when considering eyebrow rejuvenation.
Estrogen‐related receptor β activation and isoform shifting by cdc2‐like kinase inhibition restricts migration and intracranial tumor growth in glioblastoma
Tiek, Deanna , Khatib, Subreen A. , Trepicchio, Colin J., Heckler, Mary Mazzotta, Divekar, Shailaja D., Glasgow, Eric , Sarkaria, Jann N. , Riggins, Rebecca Baab

Mayo Clinic

The FASEB Journal | September 30, 2019 | Volume: 33 | Issue: 12 | Pages: 13476-13491

10.1096/fj.201901075r | PMID 31570001 Get It

Glioblastoma (GBM; grade 4 glioma) is a highly aggressive and incurable tumor. GBM has recently been characterized as highly dependent on alternative splicing, a critical driver of tumor heterogeneity and plasticity. Estrogen‐related receptor β (ERR‐β) is an orphan nuclear receptor expressed in the brain, where alternative splicing of the 3' end of the pre‐mRNA leads to the production of 3 validated ERR‐β protein products: ERR‐β short form (ERR‐βsf), ERR‐β2, and ERR‐β exon 10 deleted. Our prior studies have shown the ERR‐β2 isoform to play a role in G 2 /M cell cycle arrest and induction of apoptosis, in contrast to the function of the shorter ERR‐βsf isoform in senescence and G 1 cell cycle arrest. In this study, we sought to better define the role of the proapoptotic ERR‐β2 isoform in GBM. We show that the ERR‐β2 isoform is located not only in the nucleus but also in the cytoplasm. ERR‐β2 suppresses GBM cell migration and interacts with the actin nucleation‐promoting factor cortactin, and an ERR‐β agonist is able to remodel the actin cytoskeleton and similarly suppress GBM cell migration. We further show that inhibition of the splicing regulatory cdc2‐like kinases in combination with an ERR‐β agonist shifts isoform expression in favor of ERR‐β2 and potentiates inhibition of growth and migration in GBM cells and intracranial tumors.—Tiek, D. M., Khatib, S. A., Trepicchio, C. J., Heckler, M. M., Divekar, S. D., Sarkaria, J. N., Glasgow, E., Riggins, R. B. Estrogen‐related receptor β activation and isoform shifting by cdc2‐like kinase inhibition restricts migration and intracranial tumor growth in glioblastoma. FASEB J. 33, 13476–13491 (2019). www.fasebj.org
Evolution of Medicare Formulary Coverage Changes for Antithrombotic Therapies After Guideline Updates
Dayoub, Elias J. , Ross, Joseph S. , Shah, Nilay D. , Dhruva, Sanket S. , Ross, Joseph S

Mayo Clinic

Circulation | September 30, 2019 | Volume: 140 | Issue: 14 | Pages: 1227-1230

10.1161/circulationaha.119.040580 | PMID 31567008 Get It

Response to: ‘The efficacy and safety of endoscopic ultrasound-guided ablation of pancreatic cysts with alcohol and paclitaxel: a systematic review’
Attila, Tan, Adsay, Volkan , Faigel, Douglas O. , Adsay, N Volkan

Mayo Clinic

European Journal of Gastroenterology & Hepatology | September 30, 2019 | Volume: 31 | Issue: 11 | Pages: 1475-1475

10.1097/meg.0000000000001489 | PMID 31569124 Get It

Modulation of the autonomic nervous system through mind and body practices as a treatment for atrial fibrillation
Bashir, Majid , Bhagra, Anjali , Bashir, M Usmaan, Bashir, M. Usmaan, Kapa, Suraj , McLeod, Christopher J.

Mayo Clinic

Reviews in Cardiovascular Medicine | September 30, 2019 | Volume: 20 | Issue: 3 | Pages: No page available

10.31083/j.rcm.2019.03.517 | PMID 31601087 Get It

Atrial fibrillation is the most common symptomatic arrhythmia that is associated with stroke. Contemporary management of the disease is focused on anticoagulation to prevent stroke, coupled with catheter ablation to limit symptoms and prevent deleterious cardiac remodeling. Emerging data highlights the importance of lifestyle modification by managing sleep apnea, increasing physical activity, and weight loss. There is significant data that supports a link between the autonomic nervous system, arrhythmia development, and atrial fibrillation therapy. It is likely that lifestyle modification through these techniques that are aimed to reduce stress may also mediate atrial fibrillation development through this mechanism. This review examines how mind and body practices such as meditation, yoga, and acupuncture may influence the autonomic nervous system and mitigate atrial fibrillation progression and regression. Available evidence from molecular and anatomical levels through to clinical observations and translational clinical trials were scrutinized and a case established for these interventions as potential powerful mediators of anti-arrhythmic benefit.
Combined Tumors in Hematolymphoid Neoplasms: Case Series of Histiocytic and Langerhans Cell Sarcomas Arising From Low-Grade B-Cell Lymphoma
Skala, Stephanie L. , Ye, Jing C., Stumph, Jennifer , Macon, William R. , Quinones, Frances R, Khachaturov, Vadim, Dewar, Rajan , Skala, Stephanie L , Ye, Jing C., Ketterling, Rhett P.

Mayo Clinic

Clinical Pathology | September 30, 2019 | Volume: 12 | Issue: No issue available | Pages: No page available

10.1177/2632010x19878410 | PMID 31633108 Get It

We report an index case of histiocytic sarcoma arising in a 70-year-old patient with long-standing chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL). The patient presented in 2017 with painful, enlarging swelling of the left neck. He had remote history of cutaneous squamous cell carcinoma with no sign of recurrence, and his CLL/SLL was thought to be in remission. Computed tomography showed mild splenomegaly and multifocal lymphadenopathy including a 3-cm left neck mass. Biopsy of the left neck mass showed CLL/SLL with associated histiocytic sarcoma. Flow cytometry demonstrated a B cell neoplasm with CLL/SLL phenotype. Despite radiation therapy, he expired 3 months after presentation. Two similar cases (CLL/SLL and histiocytic sarcoma, follicular lymphoma and Langerhans cell sarcoma) from another institution are also illustrated. The pathological features of combined tumors in lymphoid neoplasms, a general framework to the work-up to determine interrelatedness of tumor components, and the clinical relevance are discussed.
ADHD Diagnosis and Treatment Guidelines: A Historical Perspective
Wolraich, Mark L., Chan, Eugenia, Froehlich, Tanya E. , Lynch, Rachel L., Bax, Ami , Redwine, Susan T., Ihyembe, Demvihin, Hagan, Joseph F.

Mayo Clinic

Pediatrics | September 30, 2019 | Volume: 144 | Issue: 4 | Pages: No page available

10.1542/peds.2019-1682 | PMID 31570649 Get It

Attention-deficit/hyperactivity disorder (ADHD) is the most common behavioral condition and the second most common chronic illness in children. The observance of specific behaviors in multiple settings have remained the most successful method for diagnosing the condition, and although there are differences in specific areas of the brain, and a high heritability estimate (∼76%), they are not diagnostically specific. Medications, and particularly stimulant medication, have undergone rigorous studies to document their efficacy dating back to the 1970s. Likewise, behavioral interventions in the form of parent training and classroom programs have demonstrated robust efficacy during the same time period. Both medication and behavioral interventions are symptomatic treatments. The availability of only symptomatic treatments places ADHD in the same category as other chronic conditions such as diabetes and asthma. Successful treatment of most individuals requires ongoing adherence to the therapy. Improved communication between patients and their families, primary and mental health providers, and school personnel is necessary for effective ADHD treatment. Further enhancement of electronic systems to facilitate family, school, and provider communication can improve monitoring of ADHD symptoms and functional performance. The American Academy of Pediatrics ADHD guidelines were initially developed to help primary care clinicians address the needs of their patients with ADHD and were further refined with the second revision in 2019.
The router bit extraction technique for removing a well-fixed humeral stem in revision shoulder arthroplasty
Kang, Jason R., Logli, Anthony L. , Tagliero, Adam J. , Sperling, John W. , Tagliero, Adam

Mayo Clinic

The Bone & Joint Journal | September 30, 2019 | Volume: 101-B | Issue: 10 | Pages: 1280-1284

10.1302/0301-620x.101b10.bjj-2018-1592.r1 | PMID 31564150 Get It

Aims A number of methods have been described to remove a well-fixed humeral implant as part of revision shoulder arthroplasty. These include the use of cortical windows and humeral osteotomies. The router bit extraction technique uses a high-speed router bit to disrupt the bone-implant interface. The implant is then struck in a retrograde fashion with a square-tip impactor and mallet. The purpose of this study was to determine the characteristics and frequency of the different techniques needed for the removal of a well-fixed humeral stem in revision shoulder arthroplasty. Patients and Methods Between 2010 and 2018, 288 revision shoulder arthroplasty procedures requiring removal of a well-fixed humeral component were carried out at a tertiary referral centre by a single surgeon. The patient demographics, indications for surgery, and method of extraction were collected. Results Of the 288 revisions, 284 humeral stems (98.6%) were removed using the router bit extraction technique alone. Four humeral stems (1.39%) required an additional cortical window. Humeral osteotomy was not necessary in any procedure. Most of the humeral stems removed (78.8%) were cementless. Of the four humeral stems that required a cortical window, three involved removal of a hemiarthroplasty. Two were cemented and two were cementless. Conclusion The router bit extraction technique removed a well-fixed humeral component in a very high proportion of patients (98.6%). This method allows surgeons to avoid more invasive approaches involving a cortical window or humeral osteotomy, and their associated complications. Cite this article: Bone Joint J 2019;101-B:1280–1284